All Alios articles
-
Business
J&J to buy antiviral specialist Alios
$1.75 billion deal brings Phase II compounds for hepatitis C and respiratory syncytial virus
$1.75 billion deal brings Phase II compounds for hepatitis C and respiratory syncytial virus